Form 4: Chemed CEO Reports Stock Transaction
Insider Transaction (Form 4)
Joel L Wherley, CEO - Vitas Healthcare of Chemed Corp, reported multiple transactions in common stock on August 5, 2026.
Summary
- Option exercise/conversion: acquired 2,599 Capital Stock at $445.35 ($1,157,465) on August 5, 2026; holds 3,451 after (Direct).
- Tax/exercise-price withholding: disposed of 2,270 Capital Stock at $542.62 ($1,231,747) on August 5, 2026; holds 1,181 after (Direct).
- Option exercise/conversion: disposed of 2,599 Stock Option (right to buy with tandem tax withholding) at $445.35 ($1,157,465) on August 5, 2026; holds 30,220 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Joel L Wherley — Officer (CEO - Vitas Healthcare)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-05 | Option exercise/conversion | Capital Stock | 2,599 | $445 | $1.2M | 3,451 |
| 2026-08-05 | Tax/exercise-price withholding | Capital Stock | 2,270 | $543 | $1.2M | 1,181 |
| 2026-08-05 | Option exercise/conversion | Stock Option (right to buy with tandem tax withholding) | 2,599 | $445 | $1.2M | 30,220 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-05 | Option exercise/conversion (2,599 shares) |
| 2026-08-05 | Tax/exercise-price withholding (2,270 shares) |
| 2026-08-05 | Option exercise/conversion (2,599 shares) |
Keywords
insider transaction, Form 4, CHE, CHEMED CORP, neutral, Joel L Wherley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.